Optiver Holding
DYN icon

Optiver Holding’s Dyne Therapeutics DYN Stock Holding History

Optiver Holding’s Portfolio DYN Stock Details DYN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-395
Closed -$7.73K – 2431
2025
Q4 		$7.73K Sell
395
-508
-56% -$9.62K ﹤0.01% 1204
2025
Q3 		$11.4K Buy
903
+150
+20% +$1.71K ﹤0.01% 1214
2025
Q2 		$7.17K Buy
753
+556
+282% +$6.12K ﹤0.01% 1107
2025
Q1 		$2.06K Buy
+197
New +$2.82K ﹤0.01% 1236

Other funds holding DYN

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return

Optiver Holding's DYN Position: Q1 2026 in Review

Optiver Holding sold out of Dyne Therapeutics (DYN) in Q1 2026, closing a stake of 395 shares — an estimated $7.73K sold.

Optiver Holding first reported a position in DYN in Q1 2025 and held it in 4 quarters. The position peaked at $11.4K in Q3 2025. 227 funds tracked by Wall St. Rank hold DYN as of Q1 2026.

  • Optiver Holding reported no remaining Dyne Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Optiver Holding sold 395 Dyne Therapeutics shares in Q1 2026, an estimated $7.73K.
  • Optiver Holding first reported a position in Dyne Therapeutics in Q1 2025 and held it in 4 quarters.
  • Optiver Holding's Dyne Therapeutics position peaked at $11.4K in Q3 2025.
  • 227 funds tracked by Wall St. Rank held Dyne Therapeutics as of Q1 2026.

Based on Optiver Holding's 13F filing for Q1 2026, filed 15 May 2026.